CF
ABBV icon

Convergence Financial’s AbbVie ABBV Stock Holding History

Convergence Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$643K Sell
2,957
-60
-2% -$13.3K 0.07% 133
2025
Q4 		$689K Sell
3,017
-73
-2% -$16.6K 0.1% 103
2025
Q3 		$715K Buy
3,090
+743
+32% +$151K 0.11% 101
2025
Q2 		$436K Buy
2,347
+999
+74% +$186K 0.07% 125
2025
Q1 		$282K Buy
+1,348
New +$262K 0.06% 140

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Convergence Financial's ABBV Position: Q1 2026 in Review

Convergence Financial reduced its AbbVie (ABBV) stake by 2% in Q1 2026, selling an estimated $13.3K and leaving 2,957 shares worth $643K. The position accounts for 0.07% of the portfolio, ranked #133.

Convergence Financial first reported a position in ABBV in Q1 2025 and has held it in 5 quarters since. The position peaked at $715K in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Convergence Financial held 2,957 shares of AbbVie worth $643K as of Q1 2026.
  • Convergence Financial sold 60 AbbVie shares in Q1 2026, an estimated $13.3K.
  • AbbVie made up 0.07% of Convergence Financial's portfolio in Q1 2026, its #133 holding.
  • Convergence Financial first reported a position in AbbVie in Q1 2025 and has held it in 5 quarters since.
  • Convergence Financial's AbbVie position peaked at $715K in Q3 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Convergence Financial's 13F filing for Q1 2026, filed 11 May 2026.